Flexibility is the new mantra among federal health policy officials, as the Obama administration rolls out alternative programs likely to appeal more to providers and patients.
Another policy change aims to boost enrollment in new insurance plans for individuals unable to purchase affordable coverage due to chronic health problems. The Pre-Existing Condition Insurance Plan was established by the Patient Protection and Affordable Care Act (PPACA) to provide coverage to high-risk patients until they can obtain insurance through exchanges in 2014.
Initially, the main fear was that the $5 billion provided for the program would be highly inadequate to fund temporary coverage for the 4 million uninsured Americans estimated to be eligible for the risk pools. But enrollment fell way short of expectations, with only about 20,000 people signed up as of May of this year. Long waiting periods, cumbersome rules and costly premiums were identified as serious impediments.
Premiums for plans operated by the federal government would drop as much as 40% in 18 states, a move that would bring rates more in line with coverage sold on the individual market. And to make enrollment easier, HHS will require only a letter from a doctor, instead of a coverage denial statement from an insurance company.
MORE ACO OPTIONS
Most notable are new initiatives to encourage healthcare providers to form Accountable Care Organizations (ACOs) and offset the vehement objections to the Medicare Shared Savings program announced in late March. A "Pioneer ACO Model" will allow established health systems such as Geisinger and Intermountain to launch Medicare ACOs quickly and to gain more of their expected savings in exchange to taking on greater financial risk.
Alternatively, an "Advance Payment Initiative" will give inexperienced ACO sponsors access to shared savings up front to help them finance these new organizations. The Centers for Medicare and Medicaid Services (CMS) also will offer learning sessions to inform ACO leaders about operating challenges and managing financial risk.
These changes aim to address provider warnings that the ACO shared savings program is too costly and restrictive. The American Hospital Assn. estimated that starting an ACO could cost a hospital $11 million to $26 million in the first year-much more than the $1.8 million suggested by CMS. The American Medical Group Assn. told CMS in May that few of its members would participate. In addition to high start-up costs, providers cite excessive quality measure requirements, retrospective attribution of patients, and an impractical patient opt-out system.
Insurers applaud efforts to move away from FFS but have raised concerns that ACOs will lead to provider consolidation. CMS is slated to issue final ACO regs in the next month or so, in order for the program to begin next year.
Jill Wechsler, a veteran reporter, has been covering Capitol Hill since 1994.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More